English Korean Chinese
ホーム > 市場調査レポート > バイオテクノロジー > バイオ機器 > 心臓バイオマーカー診断の米国市場
カテゴリ
バイオテクノロジー (1630)
オーダーメイド医療 (51)
ゲノム創薬 (203)
バイオマーカー (158)
バイオマテリアル (54)
バイオ機器 (385)
遺伝子療法/RNAi (103)
抗体/免疫 (194)
再生医療 (122)
分子標的療法 (132)
市場調査レポート

心臓バイオマーカー診断の米国市場

U.S. Cardiac Biomarkers Diagnostics Markets

発行 Frost & Sullivan
出版日 2007年12月 商品コード 58497
ページ情報 英文 61 Pages
価格
US$ 6,000 換算 ¥ 482,820 (税抜) Web Access (Regional License)
US$ 6,500 換算 ¥ 523,055 (税抜) Hard Copy & Web Access (Regional License)


原文目次

Abstract

This research service analyzes the market for cardiac biomarkers within the United States. The United States market was divided into the acute myocardial infarction diagnostics and congestive heart failure diagnostics market segments.

Table of Contents

1 EXECUTIVE SUMMARY

  • Market Overview
    • Introduction

2 TOTAL CARDIAC BIOMARKERS DIAGNOSTICS MARKET

  • Market Overview
    • Introduction
    • Research Methodology
    • Market Engineering Analysis
  • Market Segmentation and Revenue Forecasts
    • Scope and Segmentation
    • Revenue Forecasts
    • Market Share Analysis
  • Industry Challenges and Strategic Recommendations
    • Industry Challenges
    • Strategic Recommendations

3 ACUTE MYOCARDIAL INFARCTION DIAGNOSTICS MARKET

  • Market Overview
    • Introduction
    • Market Engineering Measurements
  • Market Drivers and Restraints
    • Market Drivers
    • Market Restraints
  • Market Forecast
    • Revenue Forecast
  • Competitive Analysis
    • Competitive Structure
    • Market Share Analysis
    • Product Analysis

4 CONGESTIVE HEART FAILURE DIAGNOSTICS MARKET

  • Market Overview
    • Introduction
    • Market Engineering Measurements
  • Market Drivers and Restraints
    • Market Drivers
    • Market Restraints
  • Market Forecast
    • Revenue Forecast
  • Competitive Analysis
    • Competitive Structure
    • Market Share Analysis
    • Product Analysis

5 DECISION SUPPORT DATABASES

  • Decision Support Databases
    • Number of Physicians
    • Number of Hospitals
    • Number of People Aged 65 Years and Older
Back to Top